Med. praxi. 2011;8(3):112-118

Treatment of asthma with inhaled corticosteroids

MUDr.Jiří Novák
Alergologie a imunologie při Ústřední vojenské nemocnici, Praha

The treatment of asthma in the CR is based on the materials of the GINA. For most uncontrolled asthma patients, inhaled glucocorticoid

is recommended as the inicial treatment. Except for ciclesonide, however, their local therapeutic effects cannot be separated from their

systemic side effects. Klíčová slova: Inhalační kortikosteroidy, astma, ciklesonid, budesonid, flutikason.

Keywords: inhaled corticosteroids, asthma, treatment

Published: March 23, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Novák J. Treatment of asthma with inhaled corticosteroids. Med. praxi. 2011;8(3):112-118.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Global Initiative for Astma. Global strategy for astma management and prevention. 2009 update. (2011 v tisku). www. ginasthma.org.
    2. Global Initiative for Astma. Global strategy for astma management and prevention in children 5 years and younger. 2010. www.ginasthma.org.
    3. Szefler SJ. Advances in pediatric asthma in 2009: Gaining control of childhood asthma. J Allergy Clin Immunol 2010; 125: 69-78. Go to original source... Go to PubMed...
    4. Szefler SJ, Mitchell H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner city adolescents and young adults: a randomised controlled trial. Lancet 2008; 372(9643): 1065-1072. Go to original source... Go to PubMed...
    5. Shields M. In: Sborník přednášek z 8. setkání lékařů ČR a SR. Astma a alergie z různých pohledů. Litomyšl HRG. 2008.
    6. Lipworth BJ. Systemic averse effects of inhaled corticosteroids therapy. A systematic rewiew and meta-analysis. Arch Intern Med 1999; 159: 941 - 955. Go to original source... Go to PubMed...
    7. Denburg J. In: Pendant C. Inhaled steroids in astma. New York, Basel: Marcel Decker, 2002.
    8. White M, Crisalida T, Li H. Effects of long-term inhaled corticosteroids on adrenal function in patients with asthma. Ann Allergy Asthma Immunol 2006; 96: 437-444. Go to original source... Go to PubMed...
    9. Todd GRG, Acerini CL, Warner TJ, et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002; 87: 457-461. Go to original source... Go to PubMed...
    10. Patel L, Wales JK, Kibirge MS, et al. Symptomatic adrenal insufficiency during inhaled corticosteroid treatment. Arch Dis Child 2001; 85: 330-334. Go to original source... Go to PubMed...
    11. Novák J. Bezpečnost inhalačních kortikosteroidů: Část I. Inhalační kortikosteroidy a kůra nadledvin. Alergie 2006; 7: 299-310.
    12. Richy F, Bousquet J, Ehrlich GE, et al. Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporosis int 2003; 14: 179-190. Go to original source... Go to PubMed...
    13. Novák J, Bayer M, Derner V. Effects of inhaled fluticasone propionate on bone mass in children. XV. World Congress of Asthma, Buenos Aires. Monduzzi Editore. 1999; 129-134.
    14. Novák J, Bayer M, Palička V, Víšek P. Osteoporosis and its therapy in children treated for asthma. J Allergy Clin Immunology, 2006; 117: 94. Go to original source...
    15. Kelly HW, Van Natta ML, Covar RA, et al. CAMP Research Group. Effect of long term corticosteroid use on bone mineral density in the childhood Asthma Management Program (CAMP) study. Pediatrics, 2008; 122(1): e53-e61. Go to original source... Go to PubMed...
    16. Novák J, Bayer M, Palička V, Víšek P. Výskyt a prevence osteoporózy u pacientů s asthma bronchiale. JAMA. 2002; 3(10): 201-202.
    17. Novák J. Bezpečnost inhalačních kortikosteroidů: Část II. Inhalační kortikosteroidy, astma a růst. Alergie 2007; 8: 20-31.
    18. Novák J. Bezpečnost inhalačních kortikosteroidů: Část III. Nežádoucí účinky inhalačních kortikosteroidů na oči, kůži, psychiku a metabolismus. Alergie 2007; 8: 59-65.
    19. Szefler SJ, Martin RJ, et al. For asthma clinical research network of the NHLBI. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol, 2002; 109: 410-418. Go to original source... Go to PubMed...
    20. www.Alergieimunita.cz/Články pro lékaře/Novák J. Farmakoterapie astmatu u dětí v ČR.
    21. Novák J. Inhalační kortikosteroidy u dětí. Pediatrie pro praxi; 2011, v tisku.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.